Structural insights into the interactions of repositioning and known drugs for Alzheimer’s disease with hen egg white lysozyme by MM-GBSA

References

• Arnaudov, L. N., & de Vries, R. (2015). Thermally induced fibrillar aggregation of hen egg white lysozyme. Biophysical Journal, 88(1), 515–526. https://doi.org/10.1529/biophysj.104.048819
   Google Scholar
• Athar, T., Al Balushi, K., & Khan, S. A. (2021). Recent advances on drug development and emerging therapeutic agents for Alzheimer’s disease. Molecular Biology Reports, 48(7), 5629–5645. https://doi.org/10.1007/s11033-021-06512-9
   PubMed Web of Science ®Google Scholar
• Bahramikia, S., Yazdanparast, R., & Gheysarzadeh, A. (2012). Syntheses and structure-activity relationships of seven manganese-salen derivatives as anti-amyloidogenic and fibril-destabilizing agents against hen egg-white lysozyme aggregation. Chemical Biology & Drug Design, 80(2), 227–236. https://doi.org/10.1111/j.1747-0285.2012.01391.x
   PubMed Web of Science ®Google Scholar
• Ban, D. K., Somu, P., & Paul, S. (2018). Graphene oxide quantum dot alters amyloidogenicity of hen egg white lysozyme via modulation of protein surface character. Langmuir: The ACS Journal of Surfaces and Colloids, 34(50), 15283–15292. https://doi.org/10.1021/acs.langmuir.8b02674
   PubMedGoogle Scholar
• Belwal, V. K., Datta, D., & Chaudhary, N. (2020). The β-turn-supporting motif in the polyglutamine binding peptide QBP1 is essential for inhibiting huntingtin aggregation. FEBS Letters, 594(17), 2894–2903. https://doi.org/10.1002/1873-3468.13873
   PubMed Web of Science ®Google Scholar
• Borana, M. S., Mishra, P., Pissurlenkar, R. R. S., Hosur, R. V., & Ahmad, B. (2014). Curcumin and kaempferol prevent lysozyme fibril formation by modulating aggregation kinetic parameters. Biochimica et Biophysica Acta, 1844(3), 670–680. https://doi.org/10.1016/j.bbapap.2014.01.009
   PubMed Web of Science ®Google Scholar
• Bugg, C. W., Isas, J. M., Fischer, T., Patterson, P. H., & Langen, R. (2012). Structural features and domain organization of huntingtin fibrils. The Journal of Biological Chemistry, 287(38), 31739–31746. https://doi.org/10.1074/jbc.M112.353839
   PubMed Web of Science ®Google Scholar
• Chiti, F., & Dobson, C. M. (2006). Protein misfolding, functional amyloid, and human disease. Annual Review of Biochemistry, 75(1), 333–366. https://doi.org/10.1146/annurev.biochem.75.101304.123901
   PubMed Web of Science ®Google Scholar
• Chowdhury, S., & Kumar, S. (2021). Bioactive phytocompounds: anti-amyloidogenic effects against hen egg-white lysozyme aggregation. The Protein Journal, 40(1), 78–86. https://doi.org/10.1007/s10930-020-09946-5
   PubMed Web of Science ®Google Scholar
• Crystallography: Protein data bank. Nature New Biology, 233(42), 223–223. https://doi.org/10.1038/newbio233223b0
   PubMedGoogle Scholar
• Cui, L., Wang, S., Zhang, J., Wang, M., Gao, Y., Bai, L., Zhang, H., Ma, G., & Ba, X. (2019). Effect of curcumin derivatives on hen egg white lysozyme amyloid fibrillation and their interaction study by spectroscopic methods. Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy, 223, 117365. https://doi.org/10.1016/j.saa.2019.117365
   PubMed Web of Science ®Google Scholar
• Dallakyan, S., & Olson, A. J. (2015). Small-molecule library screening by docking with PyRx. In J. Hempel, C. Williams, & C. Hong (Eds.), Chemical biology. Methods in molecular biology (Vol. 1263, pp. 243–250). Humana Press. https://doi.org/10.1007/978-1-4939-2269-7_19]
   Google Scholar
• Dileep, K. V., Nithiyanandan, K., & Remya, C. (2018). Binding of acarbose, an anti-diabetic drug to lysozyme: A combined structural and thermodynamic study. Journal of Biomolecular Structure & Dynamics, 36(13), 3354–3361. https://doi.org/10.1080/07391102.2017.1388283
   PubMed Web of Science ®Google Scholar
• Dobson, C. M. (2003). Protein folding and misfolding. Nature, 426(6968), 884–890. https://doi.org/10.1038/nature02261
   PubMed Web of Science ®Google Scholar
• Dolinsky, T. J., Czodrowski, P., Li, H., Nielsen, J. E., Jensen, J. H., Klebe, G., & Baker, N. A. (2007). PDB2PQR: Expanding and upgrading automated preparation of biomolecular structures for molecular simulations. Nucleic Acids Research, 35(Web Server issue), W522–W525. https://doi.org/10.1093/nar/gkm276
   PubMed Web of Science ®Google Scholar
• Faramarzian, M., Bahramikia, S., & Dehghan Shasaltaneh, M. (2020). In vitro investigation of the effect of mesalazine on amyloid fibril formation of hen egg-white lysozyme and defibrillation lysozyme fibrils. European Journal of Pharmacology, 874, 173011. https://doi.org/10.1016/j.ejphar.2020.173011
   PubMed Web of Science ®Google Scholar
• Ghosh, A., Panda, P., Halder, A. K., & Cordeiro, M. N. D. S. (2022). In silico characterization of aryl benzoyl hydrazide derivatives as potential inhibitors of RdRp enzyme of H5N1 influenza virus. Frontiers in Pharmacology, 13, 1004255. https://doi.org/10.3389/fphar.2022.1004255
   PubMed Web of Science ®Google Scholar
• Girych, M., Gorbenko, G., Maliyov, I., Trusova, V., Mizuguchi, C., Saito, H., & Kinnunen, P. (2016). Combined thioflavin T-Congo red fluorescence assay for amyloid fibril detection. Methods and Applications in Fluorescence, 4(3), 034010. https://doi.org/10.1088/2050-6120/4/3/034010
   PubMed Web of Science ®Google Scholar
• Halder, A. K., & Cordeiro, M. N. D. S. (2021). Multi-target in silico prediction of inhibitors for mitogen-activated protein kinase-interacting kinases. Biomolecules, 11(11), 1670. https://doi.org/10.3390/biom11111670
   PubMed Web of Science ®Google Scholar
• Halder, A. K., & Honarparvar, B. (2019). Molecular alteration in drug susceptibility against subtype B and C-SA HIV-1 proteases: MD study. Structural Chemistry, 30(5), 1715–1727. https://doi.org/10.1007/s11224-019-01305-0
   Web of Science ®Google Scholar
• Harada, A., Azakami, H., & Kato, A. (2008). Amyloid fibril formation of hen lysozyme depends on the instability of the C-helix (88-99). Bioscience, Biotechnology, and Biochemistry, 72(6), 1523–1530. https://doi.org/10.1271/bbb.80032
   PubMed Web of Science ®Google Scholar
• He, J., Wang, Y., Chang, A. K., Xu, L., Wang, N., Chong, X., Li, H., Zhang, B., Jones, G. W., & Song, Y. (2014). Myricetin prevents fibrillogenesis of hen egg white lysozyme. Journal of Agricultural and Food Chemistry, 62(39), 9442–9449. https://doi.org/10.1021/jf5025449
   PubMed Web of Science ®Google Scholar
• Howlett, G. J., Ryan, T. M., & Griffin, M. D. W. (2019). Lipid-apolipoprotein interactions in amyloid fibril formation and relevance to atherosclerosis. Biochimica et Biophysica Acta. Proteins and Proteomics, 1867(5), 502–507. https://doi.org/10.1016/j.bbapap.2018.08.010
   PubMed Web of Science ®Google Scholar
• Hudson, S. A., Ecroyd, H., Kee, T. W., & Carver, J. A. (2009). The thioflavin T fluorescence assay for amyloid fibril detection can be biased by the presence of exogenous compounds. The FEBS Journal, 276(20), 5960–5972. https://doi.org/10.1111/j.1742-4658.2009.07307.x
   PubMed Web of Science ®Google Scholar
• Jokar, S., Erfani, M., Bavi, O., Khazaei, S., Sharifzadeh, M., Hajiramezanali, M., Beiki, D., & Shamloo, A. (2020). Design of peptide-based inhibitor agent against amyloid-β aggregation: Molecular docking, synthesis and in vitro evaluation. Bioorganic Chemistry, 102, 104050. https://doi.org/10.1016/j.bioorg.2020.104050
   PubMed Web of Science ®Google Scholar
• Joshi, V., Shivach, T., Yadav, N., & Rathore, A. S. (2014). Circular dichroism spectroscopy as a tool for monitoring aggregation in monoclonal antibody therapeutics. Analytical Chemistry, 86(23), 11606–11613. https://doi.org/10.1021/ac503140j
   PubMed Web of Science ®Google Scholar
• Knorz, A. L., & Quante, A. (2022). Alzheimer’s disease: Efficacy of mono- and combination therapy. A systematic review. Journal of Geriatric Psychiatry and Neurology, 35(4), 475–486. https://doi.org/10.1177/08919887211044746
   PubMed Web of Science ®Google Scholar
• Lagunin, A. A., Ivanov, S. M., Gloriozova, T. A., Pogodin, P. V., Filimonov, D. A., Kumar, S., & Goel, R. K. (2020). Combined network pharmacology and virtual reverse pharmacology approaches for identification of potential targets to treat vascular dementia. Scientific Reports, 10(1), 257. https://doi.org/10.1038/s41598-019-57199-9
   PubMed Web of Science ®Google Scholar
• Lim, K., Nadarajah, A., Forsythe, E. L., & Pusey, M. L. (1998). Locations of bromide ions in tetragonal lysozyme crystals. Acta Crystallographica. Section D, Biological Crystallography, 54(Pt 5), 899–904. https://doi.org/10.1107/S0907444998002844
   PubMedGoogle Scholar
• Liu, L., Zhu, Y., Fu, P., & Yang, J. (2022). A network pharmacology based research on the mechanism of donepezil in treating Alzheimer’s disease. Frontiers in Aging Neuroscience, 14, 822480. https://doi.org/10.3389/fnagi.2022.822480
   PubMed Web of Science ®Google Scholar
• Liu, X., & Wang, Y. (2023). Elucidating the molecular targets and mechanisms of chlorogenic acid against Alzheimer’s disease via network pharmacology and molecular docking. Letters in Drug Design & Discovery, 20(9), 1329–1342. https://doi.org/10.2174/1570180819666220619125742
   Web of Science ®Google Scholar
• Ma, X., Zhao, Y., Yang, T., Gong, N., Chen, X., Liu, G., & Xiao, J. (2022). Integration of network pharmacology and molecular docking to explore the molecular mechanism of Cordycepin in the treatment of Alzheimer’s disease. Frontiers in Aging Neuroscience, 14, 1058780. https://doi.org/10.3389/fnagi.2022.1058780
   PubMed Web of Science ®Google Scholar
• Mahdavimehr, M., Meratan, A. A., Ghobeh, M., Ghasemi, A., Saboury, A. A., & Nemat-Gorgani, M. (2017). Inhibition of HEWL fibril formation by taxifolin: Mechanism of action. PloS One, 12(11), e0187841. https://doi.org/10.1371/journal.pone.0187841
   PubMed Web of Science ®Google Scholar
• Malcolm, B. A., Rosenberg, S., Corey, M. J., Allen, J. S., de Baetselier, A., & Kirsch, J. F. (1989). Site-directed mutagenesis of the catalytic residues Asp-52 and Glu-35 of chicken egg white lysozyme. Proceedings of the National Academy of Sciences of the United States of America, 86(1), 133–137. https://doi.org/10.1073/pnas.86.1.13
   PubMed Web of Science ®Google Scholar
• Martiz, R. M., Patil, S. M., Abdulaziz, M., Babalghith, A., Al-Areefi, M., Al-Ghorbani, M., Mallappa Kumar, J., Prasad, A., Mysore Nagalingaswamy, N. P., & Ramu, R. (2022). Defining the role of isoeugenol from ocimum tenuiflorum against diabetes mellitus-linked Alzheimer’s disease through network pharmacology and computational methods. Molecules (Basel, Switzerland), 27(8), 2398. https://doi.org/10.3390/molecules27082398
   PubMed Web of Science ®Google Scholar
• Melchor, M.-H., Susana, F.-G., Francisco, G.-S., Hiram I, B., Norma, R.-F., Jorge A, L.-R., Perla Y, L.-C., & Gustavo, B.-I. (2018). Fullerenemalonates inhibit amyloid beta aggregation, in vitro and in silico evaluation. RSC Advances, 8(69), 39667–39677. https://doi.org/10.1039/C8RA07643J
   PubMed Web of Science ®Google Scholar
• Micsonai, A., Bulyáki, É., & Kardos, J. (2021). BeStSel: From secondary structure analysis to protein fold prediction by circular dichroism spectroscopy. In Y. W. Chen & C P. B. Yiu (Eds.), Structural genomics. Methods in molecular biology (Vol. 2199, pp. 175–189). Springer. https://doi.org/10.1007/978-1-0716-0892-0_11
   Google Scholar
• Micsonai, A., Moussong, É., Wien, F., Boros, E., Vadászi, H., Murvai, N., Lee, Y.-H., Molnár, T., Réfrégiers, M., Goto, Y., Tantos, Á., & Kardos, J. (2022). BeStSel: Webserver for secondary structure and fold prediction for protein CD spectroscopy. Nucleic Acids Research, 50(W1), W90–W98. https://doi.org/10.1093/nar/gkac345
   PubMed Web of Science ®Google Scholar
• Mishra, P., Basak, S., Mukherjee, A., & Basu, A. (2022). Design and study of in silico binding dynamics of certain isoxazole bearing leads against Aβ-42 and BACE-1 loop in protein fibrillation. Letters in Drug Design & Discovery, 19(3), 192–213. https://doi.org/10.2174/1570180818666210813120444
   Web of Science ®Google Scholar
• Mishra, P., Biswas, S., Baur, S., Basak, S., Mukherjee, A., & Basu, A. (2022). Development of pyrazole harbouring novel leads against β-amyloid protein fibrillation by in silico drug design. Journal of Computational Biophysics and Chemistry, 21(05), 541–553. https://doi.org/10.1142/S2737416522500193
   Google Scholar
• Mohammadi, F., Moeeni, M., Mahmudian, A., & Hassani, L. (2018). Inhibition of amyloid fibrillation of lysozyme by bisdemethoxycurcumin and diacetylbisdemethoxycurcumin. Biophysical Chemistry, 235, 56–65. https://doi.org/10.1016/j.bpc.2018.02.005
   PubMed Web of Science ®Google Scholar
• Morshedi, D., Rezaei-Ghaleh, N., Ebrahim-Habibi, A., Ahmadian, S., & Nemat-Gorgani, M. (2007). Inhibition of amyloid fibrillation of lysozyme by indole derivatives-possible mechanism of action. The FEBS Journal, 274(24), 6415–6425. https://doi.org/10.1111/j.1742-4658.2007.06158.x
   PubMed Web of Science ®Google Scholar
• Necula, M., Kayed, R., Milton, S., & Glabe, C. G. (2007). Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct. The Journal of Biological Chemistry, 282(14), 10311–10324. https://doi.org/10.1074/jbc.M608207200
   PubMed Web of Science ®Google Scholar
• O'Boyle, N. M., Banck, M., James, C. A., Morley, C., Vandermeersch, T., & Hutchison, G. R. (2011). Open Babel: An open chemical toolbox. Journal of Cheminformatics, 3(1), 33. https://doi.org/10.1186/1758-2946-3-33
   PubMed Web of Science ®Google Scholar
• Ogata, M., Umemoto, N., Ohnuma, T., Numata, T., Suzuki, A., Usui, T., & Fukamizo, T. (2013). A novel transition-state analogue for lysozyme, 4-O-β-tri-N-acetylchitotriosyl moranoline, provided evidence supporting the covalent glycosyl-enzyme intermediate. The Journal of Biological Chemistry, 288(9), 6072–6082. https://doi.org/10.1074/jbc.M112.439281
   PubMed Web of Science ®Google Scholar
• Ose, T., Kuroki, K., Matsushima, M., Maenaka, K., & Kumagai, I. (2009). Importance of the hydrogen bonding network including Asp52 for catalysis, as revealed by Asn59 mutant hen egg-white lysozymes. Journal of Biochemistry, 146(5), 651–657. https://doi.org/10.1093/jb/mvp110
   PubMed Web of Science ®Google Scholar
• Pearlman, D. A., Case, D. A., Caldwell, J. W., Ross, W. S., Cheatham, T. E., III, DeBolt, S., Ferguson, D., Seibel, G., & Kollman, P. (1995). AMBER, a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to simulate the structural and energetic properties of molecules. Computer Physics Communications, 91(1–3), 1–41. https://doi.org/10.1016/0010-4655(95)00041-D
   Web of Science ®Google Scholar
• Pei, H., Zeng, J., Chen, W., He, Z., & Du, R. (2022). Network pharmacology and molecular docking integrated strategy to investigate the pharmacological mechanism of palmatine in Alzheimer’s disease. Journal of Biochemical and Molecular Toxicology, 36(11), e23200. https://doi.org/10.1002/jbt.23200
   PubMed Web of Science ®Google Scholar
• Pepys, M. B., Hawkins, P. N., Booth, D. R., Vigushin, D. M., Tennent, G. A., Soutar, A. K., Totty, N., Nguyen, O., Blake, C. C., & Terry, C. J. (1993). Human lysozyme gene mutations cause hereditary systemic amyloidosis. Nature, 362(6420), 553–557. https://doi.org/10.1038/362553a0
   PubMed Web of Science ®Google Scholar
• Prabhu, M. P. T., & Sarkar, N. (2022). Inhibitory effects of carbon quantum dots towards hen egg white lysozyme amyloidogenesis through formation of a stable protein complex. Biophysical Chemistry, 280, 106714. https://doi.org/10.1016/j.bpc.2021.106714
   PubMed Web of Science ®Google Scholar
• Qi, P., Li, J., Gao, S., Yuan, Y., Sun, Y., Liu, N., Li, Y., Wang, G., Chen, L., & Shi, J. (2020). Network pharmacology-based and experimental identification of the effects of quercetin on Alzheimer’s disease. Frontiers in Aging Neuroscience, 12, 589588. https://doi.org/10.3389/fnagi.2020.589588
   PubMed Web of Science ®Google Scholar
• Saeedi, M., & Mehranfar, F. (2022). Challenges and approaches of drugs such as memantine, donepezil, rivastigmine, and aducanumab in the treatment, control and management of Alzheimer’s disease. Recent Patents on Biotechnology, 16(2), 102–121. https://doi.org/10.2174/1872208316666220302115901
   PubMedGoogle Scholar
• Savva, K., Zachariou, M., Bourdakou, M. M., Dietis, N., & Spyrou, G. M. (2022). Network-based stage-specific drug repurposing for Alzheimer’s disease. Computational and Structural Biotechnology Journal, 20, 1427–1438. https://doi.org/10.1016/j.csbj.2022.03.013
   PubMed Web of Science ®Google Scholar
• Srinivasan, J., Cheatham, T. E., Cieplak, P., Kollman, P. A., & Case, D. A. (1998). Continuum solvent studies of the stability of DNA, RNA, and phosphoramidate − DNA helices. Journal of the American Chemical Society, 120(37), 9401–9409. https://doi.org/10.1021/ja981844+
   Web of Science ®Google Scholar
• Wang, K., Yang, R., Chen, T.-T., Qin, M.-R., Wang, P., & Kong, M.-W. (2022). Therapeutic mechanism of kai xin san on Alzheimer’s disease based on network pharmacology and experimental validation. Chinese Journal of Integrative Medicine, 29(5), 413–423. https://doi.org/10.1007/s11655-022-3589-5
   PubMed Web of Science ®Google Scholar
• Wu, X., Zheng, X., Tang, H., Zhao, L., He, C., Zou, Y., Song, X., Li, L., Yin, Z., & Ye, G. (2022). A network pharmacology approach to identify the mechanisms and molecular targets of curcumin against Alzheimer disease. Medicine, 101(34), e30194. https://doi.org/10.1097/MD.0000000000030194
   PubMed Web of Science ®Google Scholar
• Xiao, Q.-Y., Ye, T.-Y., Wang, X.-L., Han, L., Wang, T.-X., Qi, D.-M., Cheng, X.-R., & Wang, S.-Q. (2021). A network pharmacology-based study on key pharmacological pathways and targets of Qi Fu Yin acting on Alzheimer’s disease. Experimental Gerontology, 149, 111336. https://doi.org/10.1016/j.exger.2021.111336
   PubMed Web of Science ®Google Scholar
• Yi, P., Zhang, Z., Huang, S., Huang, J., Peng, W., & Yang, J. (2020). Integrated meta-analysis, network pharmacology, and molecular docking to investigate the efficacy and potential pharmacological mechanism of Kai-Xin-San on Alzheimer’s disease. Pharmaceutical Biology, 58(1), 932–943. https://doi.org/10.1080/13880209.2020.1817103
   PubMed Web of Science ®Google Scholar
• You, J.-S., Li, C.-Y., Chen, W., Wu, X.-L., Huang, L.-J., Li, R.-K., Gao, F., Zhang, M.-Y., Liu, H.-L., & Qu, W.-L. (2020). A network pharmacology-based study on Alzheimer disease prevention and treatment of Qiong Yu Gao. BioData Mining, 13(1), 2. https://doi.org/10.1186/s13040-020-00212-z
   PubMed Web of Science ®Google Scholar
• Zeng, P., Fang, M., Zhao, H., & Guo, J. (2021). A network pharmacology approach to uncover the key ingredients in Ginkgo Folium and their anti-Alzheimer’s disease mechanisms. Aging, 13(14), 18993–19012. https://doi.org/10.18632/aging.203348
   PubMedGoogle Scholar
• Zeng, Q., Li, L., Siu, W., Jin, Y., Cao, M., Li, W., Chen, J., Cong, W., Ma, M., Chen, K., & Wu, Z. (2019). A combined molecular biology and network pharmacology approach to investigate the multi-target mechanisms of Chaihu Shugan San on Alzheimer’s disease. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 120, 109370. https://doi.org/10.1016/j.biopha.2019.109370
   PubMed Web of Science ®Google Scholar
• Zhang, M., Schmitt-Ulms, G., Sato, C., Xi, Z., Zhang, Y., Zhou, Y., St George-Hyslop, P., & Rogaeva, E. (2016). Drug repositioning for Alzheimer’s disease based on systematic 'omics’ data mining. PloS One, 11(12), e0168812. https://doi.org/10.1371/journal.pone.0168812
   PubMed Web of Science ®Google Scholar
• Zhang, W., Lv, M., Shi, Y., Mu, Y., Yao, Z., & Yang, Z. (2021). Network Pharmacology-Based Study of the Underlying Mechanisms of Huangqi Sijunzi Decoction for Alzheimer’s Disease. Evidence-Based Complementary and Alternative Medicine: ECAM, 2021, 6480381. https://doi.org/10.1155/2021/6480381
   PubMedGoogle Scholar
• Zheng, Y., Gao, Y., Chang, Y., Sun, C., & Fang, Y. (2023). Concentration-regulated fibrillation of soy protein: Structure and in vitro digestion. Journal of Agricultural and Food Chemistry, 71(29), 11170–11179. https://doi.org/10.1021/acs.jafc.3c02206
   PubMed Web of Science ®Google Scholar